Atypical Small Cell Lung Cancer (MSK, Cancer Discov 2024)

Summary

Atypical Small Cell Lung Cancer (MSK, Cancer Discov 2024) is a study catalogued by cBioPortal DataHub under the cancer-type code lung. EvidenceHelix groups it with lung and pleura studies.

Study description

Targeted sequencing of 31 atypical small cell lung cancers lacking RB1 and TP53 co-inactivation and their matched normals via MSK-IMPACT, including structural variant analysis via whole-genome sequencing. This data is available under the Creative Commons BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en).

Text as published in the source's study metadata.

Citation & PubMed

Rekhtman N et al. Cancer Discov 2024

Linked PubMed records: PMID 39185963

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

asclc_msk_2024

Short name

not given

Source cancer-type code

lung

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Rekhtman N et al. Cancer Discov 2024

• PubMed record 39185963 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Lung Adenocarcinoma (MSK Mind,Nature Cancer 2022)

  Multimodality tools to predict response to PD-(L)1 blockade in patients with lung adenocarcinoma.

  Lung and pleuraMSK studiesSource code lungPubMed 1

• Lung Cancer (SMC, Cancer Research 2016)

  Whole exome and whole transcriptome sequencing of primary and multiple metastatic lymph node samples from 6 lung cancer patients with their matched normals.

  Lung and pleuraOther published and consortium studiesSource code lungPubMed 1

• Small Cell Lung Cancer (UC, Nature 2024)

  Whole genome and whole exome sequencing of 160 small cell lung cancer tumors and their matched normals from 65 patients.

  Lung and pleuraOther published and consortium studiesSource code lungPubMed 1

• Lung Adenocarcinoma (MSK, 2021)

  Targeted sequencing of 186 matched normal samples from 186 lung adenocarcinoma patient via MSK-IMPACT.

  Lung and pleuraMSK studiesSource code luad

• Lung Adenocarcinoma (MSK, J Thorac Oncol 2020)

  Targeted sequencing of 604 lung adenocarcinoma tumor/normal pairs via MSK-IMPACT.

  Lung and pleuraMSK studiesSource code luadPubMed 1

• Lung Adenocarcinoma (MSK, NPJ Precision Oncology 2021)

  Targeted sequencing of 426 matched normal samples from 426 lung adenocarcinoma patients.

  Lung and pleuraMSK studiesSource code luadPubMed 1

• Lung Adenocarcinoma (MSK, Science 2015)

  Whole-exome sequencing of 34 non small cell lung cancer tumor/normal pairs.

  Lung and pleuraMSK studiesSource code luadPubMed 1

• Lung Adenocarcinoma Met Organotropism (MSK, Cancer Cell 2023)

  Targeted and whole-exome sequencing of 2653 lung adenocarcinoma tumor/normal sample pairs.

  Lung and pleuraMSK studiesSource code luadPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.